Edition:
United States

Insider Trading: Merck & Co Inc (MRK)

MRK on New York Consolidated

73.19USD
18 Apr 2019
Change (% chg)

$-0.73 (-0.99%)
Prev Close
$73.92
Open
$73.48
Day's High
$74.05
Day's Low
$72.23
Volume
31,267,836
Avg. Vol
12,079,240
52-wk High
$83.85
52-wk Low
$56.26

All Insider Trades
Trading Date Name Title Type Shares Traded Price
24 Mar 2019

Davis (Robert M)

Chief Financial Officer Buy 192,572 $58.22
24 Mar 2019

Davis (Robert M)

Chief Financial Officer Sell 192,572 $82.38
19 Mar 2019

Frazier (Kenneth C)

Chief Executive Officer Sell 192,736 $82.05
19 Mar 2019

Frazier (Kenneth C)

Chief Executive Officer Buy 192,736 $39.29
12 Mar 2019

Frazier (Kenneth C)

Chief Executive Officer Sell 18,725 $82.00
12 Mar 2019

Frazier (Kenneth C)

Chief Executive Officer Buy 18,725 $39.29
4 Mar 2019

Frazier (Kenneth C)

Chief Executive Officer Sell 6,961 $82.00
4 Mar 2019

Frazier (Kenneth C)

Chief Executive Officer Buy 6,961 $39.29
3 Mar 2019

Frazier (Kenneth C)

Chief Executive Officer Sell 13,144 $82.01
3 Mar 2019

Frazier (Kenneth C)

Chief Executive Officer Buy 13,144 $39.29
24 Feb 2019

Perlmutter (Roger M)

Officer Buy 32,937 $80.38
24 Feb 2019

Frazier (Kenneth C)

Chief Executive Officer Buy 105,765 $80.38
24 Feb 2019

Deluca Richard R Jr

Officer Buy 13,507 $80.38
24 Feb 2019

Chattopadhyay (Sanat)

President Buy 10,380 $80.38
24 Feb 2019

Nally (Michael)

Officer Buy 1,527 $80.38
24 Feb 2019

Davis (Robert M)

Chief Financial Officer Buy 30,610 $80.38
24 Feb 2019

Karachun (Rita A)

Officer Buy 2,330 $80.38
24 Feb 2019

Gerberding (Julie L)

Officer Buy 8,747 $80.38
24 Feb 2019

Clyburn (Frank)

Officer Buy 4,017 $80.38
21 Feb 2019

Frazier (Kenneth C)

Chief Executive Officer Sell 53,961 $80.02
21 Feb 2019

Frazier (Kenneth C)

Chief Executive Officer Buy 53,961 $39.29
20 Feb 2019

Frazier (Kenneth C)

Chief Executive Officer Sell 41,992 $80.00
20 Feb 2019

Frazier (Kenneth C)

Chief Executive Officer Buy 41,992 $39.29
18 Feb 2019

Frazier (Kenneth C)

Chief Executive Officer Sell 42,700 $80.02
18 Feb 2019

Frazier (Kenneth C)

Chief Executive Officer Buy 42,700 $39.29

Institutional Holders

% Shares Owned: 78.34%
# of Holders: 2,853
Total Shares Held: 2,023,658,540
3 Mo. Net Change: 2,981,219
# New Positions: 41
# Closed Positions: 16
# Increased Positions: 241
# Reduced Positions: 266
# Net Buyers: -25

Officers & Directors

Name Age Since Current Position

Kenneth Frazier

63 2011 Chairman of the Board, President, Chief Executive Officer

Robert Davis

51 2014 Chief Financial Officer, Executive Vice President

Steven Mizell

58 2018 Chief Human Resource Officer

Sanat Chattopadhyay

58 2016 Executive Vice President and President - Merck Manufacturing Division

Richard DeLuca

55 2011 Executive Vice President, President - Merck Animal Health

Julie Gerberding

62 2016 Executive Vice President and Chief Patient Officer, Strategic Communications, Global Public Policy and Population Health

Roger Perlmutter

66 2013 Executive Vice President, President - Merck Research Laboratories

Rita Karachun

54 2014 Senior Vice President Finance - Global Controller

Ashley Watson

49 2015 Senior Vice President, Chief Ethics and Compliance Officer

Jim Scholefield

2018 Chief Information and Digital Officer

Michael Nally

2019 Chief Marketing Officer

Jennifer Zachary

2018 General Counsel

Frank Clyburn

2019 Chief Commercial Officer

Leslie Brun

66 2016 Lead Independent Director

Mary Coe

50 2019 Director

Thomas Cech

71 2009 Independent Director

Pamela Craig

61 2015 Independent Director

Thomas Glocer

58 2007 Independent Director

Rochelle Lazarus

71 2004 Independent Director

John Noseworthy

66 2017 Independent Director

Paul Rothman

60 2015 Independent Director

Patricia Russo

66 1995 Independent Director

Inge Thulin

65 2018 Independent Director

Wendell Weeks

59 2004 Independent Director

Peter Wendell

67 2003 Independent Director